FDA approves Arcutis’ Zoryve for the treatment of atopic dermatitis Adults and children 6 years or older are approved to use the cream. FDA approves 2 Eylea biosimilarsYesafili and Opuviz are interchangeable biosimilars to Regeneron's Eylea. Alembic intros generic Oracea Doxycycline monohydrate is a tetracycline-class drug indicated for the treatment of inflammatory lesions of rosacea in adult patients. Alembic rolls out generic Prolensa Bromfenac ophthalmic solution is a nonsteroidal anti-inflammatory drug indicated for postoperative inflammation in patients who have undergone cataract surgery. NCPA kicks off new TV ad: "PBM Career Day" The new ad is part of NCPA's campaign to push lawmakers to enact pharmacy benefit manager reform. Watch DSN: Walgreens expands role in clinical trials for greater healthcare access DSN senior reporter Sandra Levy visited Perth Amboy, N.J., to discuss the new initiative with the retailer's clinical trials team. Sponsored The 2024 Smarter Purchasing Report: Uncover 5 Key Purchasing Trends Each year, SureCost conducts extensive customer analysis and compiles the anonymized information as a resource for pharmacies. Viatris completes divestitures with closing of OTC business divestiture The completion of the OTC divestiture is a major milestone in the execution of the company's strategic plan. Albertsons taps Soda Health to bring Medicare Advantage benefits online Due to a partnership with Soda Health, Medicare Advantage coverage is now usable online at Albertsons.com. Alembic gets FDA tentative OK for generic Bosulif Bosutinib tablets are indicated for the treatment of Philadelphia chromosome-positive chronic myelogenous leukemia. First Previous 55 56 57 58 59 Next Last
